Organised screening for cervical cancer in France: a cost-effectiveness assessment.

about

Downregulation of Krüppel‑like factor 1 inhibits the metastasis and invasion of cervical cancer cells

P2860

Q58733641-52EA117E-BFAE-486A-9E40-C2EE399024E3

P2860

Organised screening for cervical cancer in France: a cost-effectiveness assessment.

Item

http://www.wikidata.org/entity/Q42376763

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Organised screening for cervical cancer in France: a cost-effectiveness assessment.

@en

Organised screening for cervical cancer in France: a cost-effectiveness assessment.

@nl

type

Item

label

Organised screening for cervical cancer in France: a cost-effectiveness assessment.

@en

Organised screening for cervical cancer in France: a cost-effectiveness assessment.

@nl

prefLabel

Organised screening for cervical cancer in France: a cost-effectiveness assessment.

@en

Organised screening for cervical cancer in France: a cost-effectiveness assessment.

@nl

P1476

Organised screening for cervical cancer in France: a cost-effectiveness assessment

@en

P2093

Frédéric De Bels

http://www.w3.org/2001/XMLSchema#string

Henri Leleu

http://www.w3.org/2001/XMLSchema#string

Stéphanie Barré

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy

Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial

Cost-effectiveness of a potential vaccine for human papillomavirus.

Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis.

The value of improving failures within a cervical cancer screening program: an example from Norway.

A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancer.

Population-level trends in relative survival for cervical cancer

Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women

Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study.

Population-based organized cervical cancer screening pilot program in France.

P304

e014626

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJOPEN-2016-014626

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marc Massetti

P577

2017-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28988162

http://www.w3.org/2001/XMLSchema#string

P932

5640017

http://www.w3.org/2001/XMLSchema#string

Organised screening for cervical cancer in France: a cost-effectiveness assessment.

about

P2860

P2860

Organised screening for cervical cancer in France: a cost-effectiveness assessment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932